biote Corp.
BTMD
$1.79
-$0.17-8.67%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 188.16M | 192.22M | 195.65M | 199.07M | 199.38M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 188.16M | 192.22M | 195.65M | 199.07M | 199.38M |
| Cost of Revenue | 56.23M | 54.86M | 54.06M | 55.80M | 57.29M |
| Gross Profit | 131.93M | 137.36M | 141.58M | 143.27M | 142.09M |
| SG&A Expenses | 103.78M | 103.26M | 105.22M | 102.67M | 105.63M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 160.01M | 158.12M | 159.28M | 158.47M | 162.92M |
| Operating Income | 28.16M | 34.10M | 36.37M | 40.60M | 36.46M |
| Income Before Tax | 23.47M | 37.58M | 30.76M | 38.17M | 21.80M |
| Income Tax Expenses | 5.03M | 5.99M | -1.70M | 2.26M | 184.00K |
| Earnings from Continuing Operations | 18.43 | 31.60 | 32.46 | 35.90 | 21.61 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -2.83M | -4.55M | -3.67M | -4.60M | -575.00K |
| Net Income | 15.60M | 27.05M | 28.79M | 31.31M | 21.04M |
| EBIT | 28.16M | 34.10M | 36.37M | 40.60M | 36.46M |
| EBITDA | 30.75M | 36.57M | 38.82M | 42.82M | 38.64M |
| EPS Basic | 0.50 | 0.86 | 0.92 | 1.00 | 0.68 |
| Normalized Basic EPS | 0.29 | 0.33 | 0.43 | 0.45 | 0.50 |
| EPS Diluted | 0.44 | 0.75 | 0.79 | 0.90 | 0.59 |
| Normalized Diluted EPS | 0.27 | 0.30 | 0.38 | 0.42 | 0.46 |
| Average Basic Shares Outstanding | 124.30M | 125.14M | 125.73M | 125.44M | 126.88M |
| Average Diluted Shares Outstanding | 135.27M | 136.23M | 142.70M | 138.25M | 139.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 10.18% | 8.44% | 7.93% | 8.71% | 25.04% |